GBD 2019 Adolescent Young Adult Cancer Collaborators. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Oncology. New York: Elsevier, 2022, vol. 23, No 1, p. 27-52. ISSN 1470-2045. Available from: https://dx.doi.org/10.1016/S1470-2045(21)00581-7.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Authors GBD 2019 Adolescent Young Adult Cancer Collaborators.
Edition The Lancet Oncology, New York, Elsevier, 2022, 1470-2045.
Other information
Original language English
Type of outcome Article in a journal
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 51.100
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/S1470-2045(21)00581-7
UT WoS 000821937900038
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 10/3/2023 10:09.
Abstract
In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15–39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults.
PrintDisplayed: 25/7/2024 03:05